
Lemonade Inc (NYSE: LMND)
Lemonade Inc (NYSE: LMND) offers insurance solutions across various categories such as renters, homeowners, auto, pet, and life insurance. It serves customers in the United States and Europe, including the UK, through a range of distribution channels.
As per our previous Kalkine’s Diversified Opportunities Report published on ‘LMND’ on 29th May 2025, Kalkine provided an ‘Buy’ stance on the stock at USD 32.53 based on “potential valuation upside, trading levels, company's accelerated growth with sequential IFP gains, driven by proprietary AI-powered precision pricing, strong telematics adoption, a doubling of cross-sells, and expanded market coverage to over 40% of the U.S. car market” and the stock price has now moved by ~ 16.26% since then and is trading above resistance 1.
Noted below are the details of support and resistance levels provided in our previous report:

Rationale – Sell at USD 37.82
Valuation (Using P/B Multiple)

Share Price Chart

Conclusion
Despite strong revenue growth, Lemonade Inc. continues to face financial headwinds, with widening net losses, negative cash flow, and rising operating expenses driven by aggressive growth spending. The company's profitability remains distant, with positive Adjusted EBITDA not expected until late 2026. Customer retention has weakened, and both gross and net loss ratios remain elevated, particularly in the Car segment. These factors reflect ongoing challenges in achieving sustainable unit economics and raise concerns about the company's path to long-term profitability.
Based on the notional gains, valuation downside and price action stance, a "Sell" recommendation on Lemonade Inc (NYSE: LMND) has been given at the current market price of USD 37.82 as on 05 June 2025 at 09:20 AM PDT.
Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is June 05, 2025. The reference data in this report has been partly sourced from REFINITIV.
Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.
Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.
Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.
Disclaimer This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.
Past performance is not a reliable indicator of future performance.